Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic Mice
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Primary and secondary hypertriglyceridemia is common in the general population, but the biochemical basis for this disease is largely unknown. With the use of transgenic technology, two lines of mice were created that express the human apolipoprotein CIII gene. One of these mouse lines with 100 copies of the gene was found to express large amounts of the protein and to be severely hypertriglyceridemic. The other mouse line with one to two copies of the gene expressed low amounts of the protein, but nevertheless manifested mild hypertriglyceridemia. Thus, overexpression of apolipoprotein CIII can be a primary cause of hypertriglyceridemia in vivo and may provide one possible etiology for this common disorder in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High ApoC-III levels were shown to increase total triglyceride levels by an accumulation of VLDL and chylomicrons [166–169]”
From Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention (2023) · cites this paper as [167]
In the citing paper
“These data are consistent with previous studies showing that transgenic mice with overexpression of human apolipoprotein C3 had hypertriglyceridemia due to decreased lipoprotein lipase activity,16”
From Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease (2010) · cites this paper as [16]
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,585
Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein
Virgil Brown, W., & Baginsky, M. L. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80149-9 · Cited by 491
Ginsberg, H. N., Le, N. A., Goldberg, I. J., Gibson, J. C., Rubinstein, A., Wang-Iverson, P., Norum, R., & Brown, W. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112713 · Cited by 424
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
Wang, C. S., McConathy, W. J., Kloer, H. U., & Alaupovic, P. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111711 · Cited by 414
Karathanasis, S. K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6374 · Cited by 358
PLASMA TRIGLYCERIDE AS A RISK FACTOR FOR CORONARY HEART DISEASE
AUSTIN, M. A. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115130 · Cited by 352
Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery Disease
Norum, R. A., Lakier, J. B., Goldstein, S., Angel, A., Goldberg, R. B., Block, W. D., Noffze, D. K., Dolphin, P. J., Edelglass, J., Bogorad, D. D., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062503 · Cited by 304
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112926 · Cited by 261
Self-citationWalsh, A., Ito, Y., & Breslow, J. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83374-9 · Cited by 241
Self-citation
Research works printed but not linked: 2
- COLE, T.G., BIOCOMMUNIQUE 4: 4 (1988).
- PROTTER, A. A., DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY 3: 449 (1984).
Cited by
Items 101–200 of 543
Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD
Taskinen, M.-R., Packard, C. J., & Borén, J. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0791-9 · Cited by 103
Adenovirus-mediated Rescue of Lipoprotein Lipase-deficient Mice
Strauss, J. G., Frank, S., Kratky, D., Hämmerle, G., Hrzenjak, A., Knipping, G., von Eckardstein, A., Kostner, G. M., & Zechner, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104430200 · Cited by 103
Eichenbaum-Voline, S., Olivier, M., Jones, E. L., Naoumova, R. P., Jones, B., Gau, B., Patel, H. N., Seed, M., Betteridge, D. J., Galton, D. J., et al. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000099881.83261.d4 · Cited by 105
Variation at the apo AI/CIII/A1V gene complex is associated with elevated plasma levels of apo CIII
Shoulders, C. C., Harry, P. J., Lagrost, L., White, S., Shah, N. F., North, J. D., Gilligan, M., Gambert, P., & Ball, M. J. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90026-y · Cited by 101
Goudriaan, J. R., Santo, S. M. S. E., Voshol, P. J., Teusink, B., van Dijk, K. W., van Vlijmen, B. J. M., Romijn, J. A., Havekes, L. M., & Rensen, P. C. N. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400009-jlr200 · Cited by 100
“Similarly, transgenic mice overexpressing the main endogenous LPL inhibitor apoC-III develop hypertriglyceridemia (26), whereas apoc3 (cid:4) / (cid:4) mice exhibit reduced plasma TG levels and are protected from postprandial hypertriglyceridemia (26, 27).”
The Importance of Lipoprotein Lipase Regulation in Atherosclerosis
Kumari, A., Kristensen, K. K., Ploug, M., & Winther, A.-M. L. (2021) · Biomedicines · doi:10.3390/biomedicines9070782 · Cited by 115
Lipolysis Stimulated Lipoprotein Receptor
Yen, F. T., Roitel, O., Bonnard, L., Notet, V., Pratte, D., Stenger, C., Magueur, E., & Bihain, B. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801027200 · Cited by 93
Voshol, P. J., Rensen, P. C. N., van Dijk, K. W., Romijn, J. A., & Havekes, L. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.12.015 · Cited by 111
Apolipoprotein CIII links dyslipidemia with atherosclerosis
Kawakami, A., & Yoshida, M. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e607 · Cited by 98
Xia, Z., Sniderman, A. D., & Cianflone, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207281200 · Cited by 100
Walsh, A., Azrolan, N., Wang, K., Marcigliano, A., O'Connell, A. M., & Breslow, J. L. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39985-5 · Cited by 98
Self-citationEffects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism
Reyes-Soffer, G., Sztalryd, C., Horenstein, R. B., Holleran, S., Matveyenko, A., Thomas, T., Nandakumar, R., Ngai, C., Karmally, W., Ginsberg, H. N., et al. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.311476 · Cited by 97
Taskinen, M.-R., & Borén, J. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0614-1 · Cited by 90
Chunyu, Z., Christina, K., Katsunori, I., & Sacks, F. M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.p600011-jlr200 · Cited by 95
The genetics of serum lipid responsiveness to dietary interventions
Ordovas, J. M. (1999) · Proceedings of the Nutrition Society · doi:10.1079/pns19990023 · Cited by 97
Corella, D., Guillén, M., Sáiz, C., Portolés, O., Sabater, A., Folch, J., & Ordovas, J. M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30148-6 · Cited by 93
Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis
Hofker, M. H., van Vlijmen, B. J. M., & Havekes, L. M. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00266-9 · Cited by 113
Structure and Dynamics of Human Apolipoprotein CIII
Gangabadage, C. S., Zdunek, J., Tessari, M., Nilsson, S., Olivecrona, G., & Wijmenga, S. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800756200 · Cited by 88
Multilocus genetic determinants of LDL particle size in coronary artery disease families.
Rotter, J. I., Bu, X., Cantor, R. M., Warden, C. H., Brown, J., Gray, R. J., Blanche, P. J., Krauss, R. M., & Lusis, A. J. (1996) · PubMed Central · Cited by 101
Molecular Cloning of a Lipolysis-stimulated Remnant Receptor Expressed in the Liver
Yen, F. T., Masson, M., Clossais‐Besnard, N., André, P., Grosset, J., Bougueleret, L., Dumas, J.-B., Guerassimenko, O., & Bihain, B. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13390 · Cited by 94
Partnership of PGC-1α and HNF4α in the Regulation of Lipoprotein Metabolism
Rhee, J., Ge, H., Yang, W., Fan, M., Handschin, C., Cooper, M., Lin, J., Li, C., & Spiegelman, B. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512636200 · Cited by 86
Hyperlipidaemia and cardioprotection: Animal models for translational studies
Andreadou, I., Schulz, R., Badimón, L., Adameová, A., Kleinbongard, P., Lecour, S., Nikolaou, P., Falcão‐Pires, I., Vilahur, G., Woudberg, N. J., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14931 · Cited by 95
Apolipoprotein CIII promotes Ca 2+ -dependent β cell death in type 1 diabetes
Juntti-Berggren, L., Refai, E., Appelskog, I., Andersson, M., Imreh, G., Dekki, N., Uhles, S., Yu, L., Griffiths, W. J., Zaitsev, S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403551101 · Cited by 86
ApoCIII Gene Variants Modulate Postprandial Response to Both Glucose and Fat Tolerance Tests
Waterworth, D. M., Ribalta, J., Nicaud, V., Dallongeville, J., Humphries, S. E., & Talmud, P. (1999) · Circulation · doi:10.1161/01.cir.99.14.1872 · Cited by 85
Waterworth, D. M., Talmud, P. J., Bujac, S. R., Fisher, R. M., Miller, G. J., & Humphries, S. E. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.12.2663 · Cited by 85
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
Chan, D. C., Chen, M. M., Ooi, E. M. M., & Watts, G. F. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01678.x · Cited by 85
Orphan Nuclear Hormone Receptor Rev-erbα Regulates the Human Apolipoprotein CIII Promoter
Coste, H., & Rodrı́guez, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203421200 · Cited by 83
Zhong, S., Goldberg, I. J., Bruce, C., Rubin, E. M., Breslow, J. L., & Tall, A. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117614 · Cited by 91
Self-citationBaroukh, N., Bauge, E., Akiyama, J., Chang, J., Afzal, V., Fruchart, J.-C., Rubin, E. M., Fruchart-Najib, J., & Pennacchio, L. A. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000130463.68272.1d · Cited by 81
Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in Type II diabetes
Gervaise, N., Garrigue, M. A., Lasfargues, G., & Lecomte, P. (2000) · Diabetologia · doi:10.1007/s001250051366 · Cited by 85
Naiki, T., Nagaki, M., Shidoji, Y., Kojima, H., Imose, M., Kato, T., Ohishi, N., Yagi, K., & Moriwaki, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105403200 · Cited by 92
Vercesi, A. E. (2006) · Frontiers in bioscience · doi:10.2741/1990 · Cited by 82
Mann, C. J., Troussard, A. A., Yen, F. T., Hannouche, N., Najib, J., Fruchart, J.-C., Lotteau, V., André, P., & Bihain, B. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31348 · Cited by 77
Tybjærg‐Hansen, A., Nordestgaard, B. G., Gerdes, L. U., Færgeman, O., & Humphries, S. E. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90202-6 · Cited by 89
Regulation of Hepatic ApoC3 Expression by PGC-1β Mediates Hypolipidemic Effect of Nicotinic Acid
Hernandez, C., Molusky, M., Li, Y., Li, S., & Lin, J. D. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.001 · Cited by 79
Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin Resistance
Castellani, L. W., Nguyen, C. N., Charugundla, S., Weinstein, M. M., Doan, C. X., Blaner, W. S., Wongsiriroj, N., & Lusis, A. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708995200 · Cited by 80
Lipoprotein metabolism in chronic renal insufficiency
Saland, J. M., & Ginsberg, H. N. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0467-5 · Cited by 87
Murray, I. V. J., Sniderman, A. D., Havel, P. J., & Cianflone, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36219 · Cited by 91
Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes
Zannis, V. I., Kardassis, D., & Zanni, E. E. (1993) · Advances in Human Genetics 21 · doi:10.1007/978-1-4615-3010-7_3 · Cited by 78
Xu, C., Talmud, P., Schuster, H., Houlston, R., Miller, G., & Humphries, S. (1994) · Clinical Genetics · doi:10.1111/j.1399-0004.1994.tb04404.x · Cited by 77
Staels, B., Schoonjans, K., Fruchart, J., & Auwerx, J. H. (1997) · Biochimie · doi:10.1016/s0300-9084(97)81497-6 · Cited by 88
Skeletal muscle metabolism in physiology and in cancer disease
Giordano, A. M., Calvani, M., Petillo, O., Carteni', M., Melone, M. A. B., & Peluso, G. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10601 · Cited by 81
Common Genomic Variation in the APOC3 Promoter Associated With Variation in Plasma Lipoproteins
Hegele, R. A., Connelly, P. W., Hanley, A. J. G., Sun, F., Harris, S. B., & Zinman, B. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2753 · Cited by 74
Dallongeville, J., Baugé, E., Tailleux, A., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., & Staels, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008809200 · Cited by 75
Campos, H., Perlov, D., Khoo, C., & Sacks, F. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31574-1 · Cited by 73
Austin, M. A., Talmud, P. J., Luong, L.-A., Haddad, L., Day, I. N. M., Newman, B. M., Edwards, K. L., Krauss, R. M., & Humphries, S. E. (1998) · The American Journal of Human Genetics · doi:10.1086/301712 · Cited by 74
Verrijken, A., Beckers, S., Francque, S., Hilden, H., Caron, S., Zegers, D., Ruppert, M., Hubens, G., Van Marck, E., Michielsen, P., et al. (2013) · Obesity · doi:10.1002/oby.20366 · Cited by 65
Apolipoprotein C-III: Going Back to the Future for a Lipid Drug Target
Huff, M. W., & Hegele, R. A. (2013) · Circulation Research · doi:10.1161/circresaha.113.301464 · Cited by 70
Chan, D. C., Watts, G. F., Nguyen, M. N., & Barrett, P. H. R. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000203519.25116.54 · Cited by 70
Butler, A. A., Zhang, J., Price, C. A., Stevens, J. R., Graham, J. L., Stanhope, K. L., King, S. M., Krauss, R. M., Bremer, A. A., & Havel, P. J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007528 · Cited by 74
Receptor-mediated mechanisms of lipoprotein remnant catabolism
Chappell, D. A., & Medh, J. D. (1998) · Progress in Lipid Research · doi:10.1016/s0163-7827(98)00017-4 · Cited by 86
Tall, A. R. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01133.x · Cited by 80
Wolska, A., Lo, L., Sviridov, D. O., Pourmousa, M., Pryor, M., Ghosh, S. S., Kakkar, R., Davidson, M., Wilson, S., Pastor, R. W., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw7905 · Cited by 70
Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors
Morel, S., Leahy, J., Fournier, M., Lamarche, B., Garofalo, C., Grimard, G., Poulain, F., DELVIN, E. E., Laverdière, C., Krajinović, M., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m072207 · Cited by 81
Antisense Technology: An Emerging Platform for Cardiovascular Disease Therapeutics
Lee, R. G., Crosby, J., Baker, B. F., Graham, M. J., & Crooke, R. M. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9495-7 · Cited by 65
Animal models of human lipid metabolism
Suckling, K. E., & Jackson, B. (1993) · Progress in Lipid Research · doi:10.1016/0163-7827(93)90002-e · Cited by 73
Atorvastatin Improves Postprandial Lipoprotein Metabolism in Normolipidemic Subjects1
Parhofer, K. G., Barrett, P. H. R., & Schwandt, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6978 · Cited by 65
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance
Packard, C. J., Pirillo, A., Tsimikas, S., Ference, B. A., & Catapano, A. L. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvad177 · Cited by 61
Models to Study Atherosclerosis: A Mechanistic Insight
Singh, V., Tiwari, R. L., Dikshit, M., & Barthwal, M. K. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109787354097 · Cited by 69
Ginsberg (2011) · doi:10.1161/atvbaha.110.221846 · Cited by 64
Norum, K. R. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1992.tb01287.x · Cited by 76
Zeng, Q., Dammerman, M., Takada, Y., Matsunaga, A., Breslow, J. L., & Sasaki, J. (1995) · Human Genetics · doi:10.1007/bf00208957 · Cited by 63
Self-citationIncreased apoC-III production is a characteristic feature of patients with hypertriglyceridemia
Cohn, J. S., Tremblay, M., Batal, R., Jacques, H., Rodriguez, C., Steiner, G. A., Mamer, O., & Davignon, J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.06.011 · Cited by 62
Beigneux, A. P., Davies, B. S. J., Bensadoun, A., Fong, L. G., & Young, S. G. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800030-jlr200 · Cited by 59
Narvekar, P., Díaz, M. B., Krones, A., Hardeland, U., Strzoda, D., Stöhr, S., Frohme, M., & Herzig, S. (2009) · Diabetes · doi:10.2337/db08-1184 · Cited by 65
Murray, I., Sniderman, A. D., & Cianflone, K. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.3.e474 · Cited by 62
Shoulders, C. C., Grantham, T. T., North, J. D., Gaspardone, A., Tomai, F., de Fazio, A., Versaci, F., Gioffrè, P. A., & Cox, N. J. (1996) · Human Genetics · doi:10.1007/s004390050259 · Cited by 60
ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
Ramms, B., Patel, S., Nora, C., Pessentheiner, A. R., Chang, M. W., Green, C. R., Golden, G. J., Secrest, P., Krauss, R. M., Metallo, C. M., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m093740 · Cited by 59
“For analysis of FA incorporation into the TCA cycle, hepatocytes were incubated for 1 h or 4 h with serum-free DMEM supplemented with 20 M U-[ 13 C 16 ]palmitic acid conjugated in a 3:1 ratio with BSA.”
InfluentialAllelic and phenotypic spectrum of plasma triglycerides
Johansen, C. T., & Hegele, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.007 · Cited by 61
Inhibition of hepatocyte nuclear factor 4 transcriptional activity by the nuclear factor κB pathway
Nikolaidou-Neokosmidou, V., Zannis, V. I., & Kardassis, D. (2006) · Biochemical Journal · doi:10.1042/bj20060169 · Cited by 61
Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice
Qu, S., Perdomo, G., Su, D., D’Souza, F. M., Shachter, N. S., & Dong, H. H. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600498-jlr200 · Cited by 59
CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery
Papp, T. E., Zeng, J., Shahnawaz, H., Akyianu, A., Breda, L., Yadegari, A., Steward, J., Shi, R., Li, Q., Mui, B. L., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.018 · Cited by 64
Sakurai, T., Sakurai, A., Vaisman, B. L., Amar, M. J., Liu, C., Gordon, S. M., Drake, S. K., Pryor, M., Sampson, M. L., Yang, L., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.229740 · Cited by 63
Ruiz-Narváez, E., Yang, Y., Nakanishi, Y., Kirchdorfer, J., & Campos, H. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500040-jlr200 · Cited by 61
Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL
Larsson, M., Allan, C. M., Jung, R. S., Heizer, P. J., Beigneux, A. P., Young, S. G., & Fong, L. G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m078220 · Cited by 53
Westerterp, M., de Haan, W., Berbeée, J. F. P., Havekes, L. M., & Rensen, P. C. N. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500434-jlr200 · Cited by 53
Koska, J., Yassine, H., Trenchevska, O., Sinari, S., Schwenke, D. C., Yen, F. T., Billheimer, D., Nelson, R. W., Nedelkov, D., & Reaven, P. D. (2016) · Journal of Lipid Research · doi:10.1194/jlr.p064816 · Cited by 55
Edwards, I. J., Rudel, L. L., Terry, J. G., Kemnitz, J. W., Weindruch, R., & Cefalu, W. T. (1998) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/53a.6.b443 · Cited by 55
Transgenic Mice in Cardiovascular Research
Field, L. J. (1993) · Annual Review of Physiology · doi:10.1146/annurev.ph.55.030193.000525 · Cited by 56
Wei, J., Ouyang, H., Wang, Y., Pang, D., Cong, N. X., Wang, T., Leng, B., Li, D., Li, X., Wu, R., et al. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08401.x · Cited by 50
Prediction of genetic risk for dyslipidemia
Yamada, Y., Matsuo, H., Warita, S., Watanabe, S., Kato, K., Oguri, M., Yokoi, K., Metoki, N., Yoshida, H., Satoh, K., et al. (2007) · Genomics · doi:10.1016/j.ygeno.2007.08.001 · Cited by 63
Complexities of plasma apolipoprotein C-III metabolism
Sacks, E. B., Zheng, C., & Cohn, E. B. (2011) · Journal of Lipid Research · doi:10.1194/jlr.e015701 · Cited by 51
Mehlum, A., Staels, B., Duverger, N., Tailleux, A., Castro, G., Fievet, C., Luc, G., Fruchart, J.-C., Olivecrona, G., Skretting, G., et al. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0567h.x · Cited by 55
The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis
Gordts, P. L. S. M., & Esko, J. D. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.05.010 · Cited by 54
Pavlic, M., Valéro, R., Duez, H., Xiao, C., Szeto, L., Patterson, B. W., & Lewis, G. F. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.169383 · Cited by 51
Naoumova, R. P., Bonney, S. A., Eichenbaum‐Voline, S., Patel, H. N., Jones, B., Jones, E. L., Amey, J. S., Colilla, S., Neuwirth, C. K. Y., Allotey, R., et al. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000095975.35247.9f · Cited by 57
Novel genes for familial combined hyperlipidemia
Aouizerat, B. E., Allayee, H., Bodnar, J. S., Krass, K. L., Peltonen, L., de Bruin, T. W., Rotter, J. I., & Lusis, A. J. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199904000-00005 · Cited by 57
Basu, D., & Bornfeldt, K. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00504 · Cited by 52
Hypertriglyceridaemia and vascular risk
Tan, K. C. B., Betteridge, D. J., Marmot, M. G., Talmud, P. J., Humphries, S. E., & Yudkin, J. S. (1993) · The Lancet · doi:10.1016/0140-6736(93)91544-v · Cited by 52
Zheng, C. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000040 · Cited by 50
The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides
Yassine, H. N., Trenchevska, O., Ramrakhiani, A., Parekh, A., Koška, J., Walker, R. W., Billheimer, D. D., Reaven, P. D., Yen, F. T., Nelson, R. W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144138 · Cited by 51
Dallinga-Thie, G. M., Berk-Planken, I. I. L., Bootsma, A. H., Jansen, H., & on behalf of the Diabetes Atorvastatin Lipid Intervention (DALI) Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1358 · Cited by 51
Lackner, K. J., Dieplinger, H., Nowicka, G., & Schmitz, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116830 · Cited by 51
Shimokata, K., Yamada, Y., Kondo, T., Ichihara, S., Izawa, H., Nagata, K., Murohara, T., Ohno, M., & Yokota, M. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.09.019 · Cited by 50
Salerno, A. G., SILVA, T. R. D., do Amaral, M. E. C., Alberici, L. C., Bonfleur, M. L., Patrício, P. R., Francesconi, E. P. M. S., Kassisse, D. M. G., Vercesi, A. E., Boschero, A. C., et al. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803646 · Cited by 53
Talianidis, I., Tambakaki, A., Toursounova, J., & Zannis, V. I. (1995) · Biochemistry · doi:10.1021/bi00032a025 · Cited by 58
Insulin Regulation of Hepatic Lipid Homeostasis
Uehara, K., Santoleri, D., Whitlock, A. E. G., & Titchenell, P. M. (2023) · Comprehensive Physiology · doi:10.1002/cphy.c220015 · Cited by 49
Zampino, R., Coppola, N., Cirillo, G., Boemio, A., Pisaturo, M., Marrone, A., Macera, M., Sagnelli, E., Perrone, L., Adinolfi, L. E., et al. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12053 · Cited by 49
Mendelian Disorders of High-Density Lipoprotein Metabolism
Oldoni, F., Sinke, R. J., & Kuivenhoven, J. A. (2014) · Circulation Research · doi:10.1161/circresaha.113.300634 · Cited by 49
Sparks, J. D., Phung, T. L., Bolognino, M., Cianci, J., Khurana, R., Peterson, R. G., Sowden, M. P., Corsetti, J. P., & Sparks, C. E. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90298-0 · Cited by 61
Metadata
- Authors
- Ito, Y., Azrolan, N., O'Connell, A., Walsh, A., & Breslow, J. L.
- Affiliations
- Rockefeller University (US)
- Venue
- Science
- Published
- 1990-08-17
- Volume
- 249
- Issue
- 4970
- Pages
- 790-793
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1963872182
- Semantic Scholar
- be3dbcf0ed6239b54ab96520181db05f1ba0399f
- Cited by
- 539
- References
- 32
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 7 · 2023: 9 · 2022: 7 · 2021: 10 · 2020: 9 · 2019: 16 · 2018: 10 · 2017: 17 · 2016: 13 · 2015: 15 · 2014: 16 · 2013: 18 · 2012: 7
- FWCI
- 21.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl033714-17, 5r37hl036461-09)
- National Heart, Lung, and Blood Institute (HL 33714, HL-36461, HL-33435)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- hypertriglyceridemia, apolipoprotein C-III, transgenic mice, gene overexpression, primary hypertriglyceridemia, secondary hypertriglyceridemia, triglyceride metabolism, gene dosage
- MeSH terms
- Animals, Apolipoproteins C, Chylomicrons, Cloning, Molecular, DNA Restriction Enzymes, DNA, Recombinant, Humans, Lipoproteins, VLDL, Mice, Inbred CBA, Mice, Inbred C57BL, Mice, Transgenic, Nucleic Acid Hybridization, RNA, Messenger, Triglycerides, Hypertriglyceridemia, Gene Expression, Mice, Apolipoprotein C-III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.